<DOC>
	<DOCNO>NCT01055379</DOCNO>
	<brief_summary>The primary endpoint study clinical response 12 week treatment , define change total score baseline depressive symptom measure Beck Depression Inventory-Amended ( BDI-IA ) total score .</brief_summary>
	<brief_title>Rasagiline Cognitive-impairment Related Depression : AzileCt COgnitive-impairment Related DepressiOn</brief_title>
	<detailed_description>ACCORDO multicentre , randomise , double-blind , placebo-controlled study conduct 12 Italian centre . Subjects screen mean BDI-IA ( cut-off 15 ) randomise treatment rasagiline placebo 12 week . Subjects stable treatment dopaminergic agent least 4 week baseline , maintain course study . The primary objective evaluate whether rasagiline compare placebo improve depressive symptom evaluate BDI-IA total score .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>Outpatient , male female age &gt; =40 &lt; 80 year . The subject diagnosis idiopathic Parkinson 's Disease ( PD ) accord United Kingdom Parkinson 's Disease Society brain bank diagnostic criterion PD clinical diagnosis PD . Depressive symptom minimum severity &gt; =15 use BDIIA . Hoehn Yahr stage IIII . Under stable ( 4 week prior baseline ) dopaminergic treatment without significant motor complication `` onoff '' phenomenon and/or dyskinesia . The subject and/or legal representative and/or impartial witness is/are able read understand Subject Information Sheet . The subject and/or legal representative has/have sign Informed Consent Form ( ICF ) relevant impartial witness cosign ICF . If female , must : agree try become pregnant study ( female patient childbearing potential take pregnancy test , use urine stick ) , AND use adequate contraception ( adequate contraception define oral/systemic contraception , intrauterine device , diaphragm combination spermicidal , condom male partner combination spermicidal ) , OR menopausal least 24 month prior baseline , ( OR ) surgically sterilise prior baseline , OR hysterectomy prior baseline . A subject , meet one follow criterion Baseline Visit , eligible inclusion study : Motor complication wear onoff phenomenon . MiniMental State Examination ( MMSE ) &lt; 26 , correct score . Diagnosis current history major depressive episode accord DSMIVTRÂ® criterion within 1 year recruitment study . Presence neurodegenerative disorder PD , base judgement investigator . Psychotic symptom , e.g . hallucination delirium ( determined clinical evaluation ) . Presence unstable untreated systemic disorder diabetes , cardiac failure , renal failure . Use prohibit concomitant medication accord timeline provide Appendix II . Patient undergone Deep Brain Stimulation surgery . Current treatment antidepressant history treatment antidepressant less 1 month prior randomisation . Current treatment history treatment le 1 month prior randomisation , antipsychotic , cholinesterase inhibitor , memantine , amantadine , anticholinergic . Current treatment selegiline history treatment selegiline le 90 day prior randomisation .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rasagiline</keyword>
	<keyword>Depressive Symptoms</keyword>
	<keyword>Cognition</keyword>
</DOC>